Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Anika Therapeutics Inc (NASDAQ:ANIK)

37.90
Delayed Data
As of Jul 31
 +1.39 / +3.81%
Today’s Change
31.36
Today|||52-Week Range
47.35
-6.97%
Year-to-Date
No recent news for Anika Therapeutics Inc.

Today’s Trading

Previous close36.51
Today’s open36.98
Day’s range36.62 - 38.48
Volume280,833
Average volume (3 months)141,420
Market cap$517.6M
Dividend yield--
Data as of 3:59pm ET, 07/31/2015

Growth & Valuation

Earnings growth (last year)+80.58%
Earnings growth (this year)-50.00%
Earnings growth (next 5 years)+30.00%
Revenue growth (last year)+40.64%
P/E ratio21.5
Price/Sales5.89
Price/Book2.95

Competitors

 Today’s
change
Today’s
% change
CERSCerus Corp+0.09+1.69%
BLCMBellicum Pharmaceuti...+0.35+1.75%
INOInovio Pharmaceutica...+0.08+1.11%
ANGOAngioDynamics Inc+0.29+1.91%
Data as of 3:59pm ET, 07/31/2015

Financials

Next reporting dateOctober 27, 2015
EPS forecast (this quarter)$0.33
Annual revenue (last year)$105.6M
Annual profit (last year)$38.3M
Net profit margin36.29%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Charles H. Sherwood
Chief Operating Officer
Francesco J. Luppino
Corporate headquarters
Bedford, Massachusetts

Forecasts